fda semaglutide shortage resolved february 21 2025 feb Novo's Wegovy and Ozempic removed from US list, compounders on notice FDA Declares Shortage of Novo – compounded semaglutide deadline As of

US consumption has risen five-fold in 50 years

While theres no proven treatment to reverse NAION damage, early management may help prevent further vision loss

There is no established link between routine GLP-1 use and a need for enzyme supplementation, although it's worth noting that pancreatitis is a rare adverse effect that can affect enzyme production

Maintaining it is hard

Useful questions to ask FeelGood before enrollment include: Who stores patient intake and health information

We have patients that are on these medicines, and we need to better understand the potential effects of GLP-1s on ADHD symptoms directly and potential side effects. Until scientists have more answers, Adler urged patients not to take matters into their own hands